|
Category: information only not used for fragrances or flavors
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
| Appearance: | white crystalline powder (est) |
| Assay: | 97.00 to 100.00 %
|
| Food Chemicals Codex Listed: | No |
| Melting Point: | 173.00 to 174.00 °C. @ 760.00 mm Hg
|
| Boiling Point: | 299.00 to 300.00 °C. @ 760.00 mm Hg (est)
|
| Vapor Pressure: | 0.001000 mmHg @ 25.00 °C. (est) |
| Flash Point: | 274.00 °F. TCC ( 134.60 °C. ) (est)
|
| logP (o/w): | 1.005 (est) |
| Soluble in: |
| | alcohol | | | water, 1210 mg/L @ 21C (exp) |
Organoleptic Properties:
| |
| Odor and/or flavor descriptions from others (if found). |
| |
| |
Cosmetic Information:
Suppliers:
Safety Information:
| Preferred SDS: View |
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
oral-rat LD50 3200 mg/kg Arzneimittel-Forschung. Drug Research. Vol. 8, Pg. 150, 1958.
oral-rabbit LD50 4000 mg/kg Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 52, Pg. 215, 1956.
oral-mouse LD50 700 mg/kg FAO Nutrition Meetings Report Series. Vol. 44A, Pg. 100, 1967.
oral-child LDLo 400 mg/kg GASTROINTESTINAL: NAUSEA OR VOMITING
BEHAVIORAL: MUSCLE WEAKNESS
BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS" Medizinische Klinik. Vol. 43, Pg. 105, 1948.
oral-dog LDLo 1000 mg/kg "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1345, 1935.
intraperitoneal-mouse LDLo 135 mg/kg BEHAVIORAL: GENERAL ANESTHETIC
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) Journal of Pharmacology and Experimental Therapeutics. Vol. 54, Pg. 188, 1935.
oral-woman LDLo 600 mg/kg BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)
BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS" Medizinische Klinik. Vol. 43, Pg. 105, 1948.
|
| Dermal Toxicity: |
|
Not determined
|
| Inhalation Toxicity: |
|
Not determined
|
Safety in Use Information:
| Category: | information only not used for fragrances or flavors |
| Recommendation for dulcin usage levels up to: | | | not for fragrance use.
|
| |
| Recommendation for dulcin flavor usage levels up to: |
| | not for flavor use.
|
Safety References:
References:
Other Information:
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| | amino-N-(4-ethoxyphenyl)amide | | 4- | ethoxy-phenylurea | | 4- | ethoxyphenyl urea | | (4- | ethoxyphenyl)urea | | 1-(4- | ethoxyphenyl)urea | | N-(4- | ethoxyphenyl)urea | | 4- | ethoxyphenylurea | | p- | ethoxyphenylurea | | | phenetolcarbamide | | p- | phenetolecarbamide | | para- | phenetolecarbamide | | | sucrol | | | suesstoff | | | urea, (4-ethoxyphenyl)- | | | urea, (p-ethoxyphenyl)- | | | urea, N-(4-ethoxyphenyl)- | | | valzin |
Articles:
|